Belgium and the Netherlands are pushing for a need-driven research model prioritising society’s requirements, with an on emphasis addressing unmet medical needs. Belgium is setting the stage for future presidencies, with the Netherlands providing research insights.
Currently, private R&D investments are guided by expected returns, with regulatory incentives being supply-driven. The EU now has an opportunity to direct innovation towards unmet medical needs.
In April, the Federal Agency for Medicines and Health Products (FAMHP), the National Institute for Health and Disability Insurance (NIHDI), and the Belgian Health Care Knowledge…
